Immunocore Holdings plc / "Benefits" | Tables in SEC filings

IMCR Immunocore Holdings plc

12 Apr 24

Definitive proxy

4:20pm

TABLE OF CONTENTS

50.	Omission to give notice and non-receipt of notice	19
51.	Postponement of general meeting	19
52.	Quorum at general meeting meetings	19
53.	Procedure if quorum not present	20
54.	Chair of general meeting	20
55.	Entitlement to attend, speak and participate	20
56.	Adjournments	20
57.	Notice of adjournment	21
58.	Business of adjourned meeting	21
59.	Security arrangements and orderly conduct	21
60.	Overflow meeting rooms	22
61.	Amendment to resolutions	22
62.	Withdrawal and ruling amendments out of order	22
63.	Members’ resolutions	22
64.	Method of voting	23
65.	Objection to error in voting	23
66.	Voting Procedure	23
67.	Votes of members	23
68.	No right to vote where sums overdue on shares	24
69.	Voting by Proxy	24
70.	Receipt of proxy	25
71.	Revocation of proxy	26
72.	Availability of appointments of proxy	26
73.	Corporate representatives	26
74.	Failure to disclose interests in shares	27
75.	Power of sale of shares of untraced members	28
76.	Application of proceeds of sale of shares of untraced members	29
77.	Number of Directors	29
78.	Power of company to appoint Directors	29
79.	Power of Board to appoint Directors	29
80.	Eligibility of new Directors	29
81.	Classes and Retirement of Directors	30
82.	Deemed re-appointment	30
83.	Procedure if insufficient Directors appointed	30
84.	Removal of Directors	31
85.	Vacation of office by Director	31
86.	Resolution as to vacancy conclusive	31
87.	Appointment of alternate Directors	31
88.	Alternate Directors’ participation in Board meetings	32
89.	Alternate Director responsible for own acts	32
90.	Interests of alternate Director	32
91.	Revocation of alternate Director	32
92.	Directors’ fees	32
93.	Expenses	32
94.	Additional remuneration	33
95.	Remuneration of executive Directors	33
96.	Pensions and other benefits	33
97.	Powers of the Board	33
98.	Powers of Directors if less than minimum number	33
99.	Powers of executive Directors	34
100.	Delegation to committees	34

	Percentage change 2022-2023			Percentage change 2021-2022
	Base salary / fees	Benefits	Bonus	Base salary / fees	Benefits	Bonus
Executive Directors
Bahija Jallal	5.0%	-1.7%	-7.6%	0.0%	49.1%	25.0%
Non-Executive Directors
Professor Sir John Bell	6.9%	—	—	20.9%	—	—
Travis Coy	—	—	—	—	—	—
Roy Herbst, M.D., Ph.D.	8.9%	—	—	19.9%	—	—
Robert Perez	—	—	—	—	—	—
Kristine Peterson	13.3%	—	—	25.9%	—	—
Professor Sir Peter Ratcliffe	2.7%	—	—	21.9%	—	—
Siddharth Kaul	87.7%	—	—	—	—	—
Average pay of employees as a whole	7.9%	10.8%	18.3%	13.1%	13.8%	9.1%

Name	Salary and Fees $	Benefits(1) $	Pension (401(k)) $	Total Fixed Remuneration $	Annual Bonus(2) $	Share- based Awards(3) $	Total Variable Remuneration $	Total Remuneration $
Executive Director:
Bahija Jallal, Ph.D.	700,000	46,106	15,250	761,356	656,250	—	656,250	1,417,606
Non-Executive Directors:
Professor Sir John Bell	85,288	—	—	85,288	—	—	—	85,288
Travis Coy(4)	—	—	—	—	—	—	—	—
Roy Herbst, M.D., Ph.D.	56,199	—	—	56,199	—	—	—	56,199
Robert Perez(4)	—	—	—	—	—	—	—	—
Kristine Peterson	56,219	—	—	56,219	—	—	—	56,219
Professor Sir Peter Ratcliffe	57,158	—	—	57,158	—	—	—	57,158
Siddharth Kaul	32,610	—	—	32,610	—	—	—	32,610
Total director compensation	987,474	46,106	15,250	1,048,830	656,250	—	656,250	1,705,080

Name	Type of Termination	Base Salary ($)	Bonus ($)(1)	Accelerated Vesting of Equity Awards(2) ($)	Continuation of Insurance Coverage ($)(3)	Total ($)
Bahija Jallal	Termination without Cause or with Good Reason	1,102,500	—	—	38,034	1,140,534
Bahija Jallal	Termination without Cause or with Good Reason in connection with a CIC	1,470,000	1,653,750	46,171,084	50,712	49,345,546
Brian Di Donato	Termination without Cause or with Good Reason	436,000	—	—	32,737	468,737
Brian Di Donato	Termination without Cause or with Good Reason in connection with a CIC	654,000	436,000	11,466,935	49,106	12,606,041
David Berman	Termination without Cause or with Good Reason	515,000	—	—	32,737	547,737
David Berman	Termination without Cause or with Good Reason in connection with a CIC	772,500	515,000	9,838,389	49,106	11,174,995
Tina St. Leger(4)	Termination without Cause or with Good Reason	338,458	—	—	4,253	342,711
Tina St. Leger(4)	Termination without Cause or with Good Reason in connection with a CIC	507,687	338,458	1,732,739	6,379	2,585,263

Name	Salary and Fees $	Benefits(1) $	Pension (401(k)) $	Total Fixed Remuneration $	Annual Bonus(2) $	Share- based Awards(3) $	Total Variable Remuneration $	Total Remuneration $
Executive Director:
Bahija Jallal, Ph.D.	735,000	45,329	16,500	796,829	606,375(2)	—	606,375	1,403,204
Non-Executive Directors:
Professor Sir John Bell	91,199	—	—	91,199	—	—	—	91,199
Travis Coy(4)	—	—	—	—	—	—	—	—
Roy Herbst, M.D., Ph.D.	61,199	—	—	61,199	—	—	—	61,199
Robert Perez(4)	—	—	—	—	—	—	—	—
Kristine Peterson	63,699	—	—	63,699	—	—	—	63,699
Professor Sir Peter Ratcliffe	58,699	—	—	58,699	—	—	—	58,699
Siddharth Kaul	61,199	—	—	61,199	—	—	—	61,199
Total director compensation	1,070,995	45,329	16,500	1,132,824	606,375	—	606,375	1,739,199

Table search / Immunocore Holdings plc / "Benefits"

5 results

Top filers

Top filing types

Recent filing years